Novavax, Inc.

NASDAQ:NVAX   3:59:54 PM EDT
42.27
+0.80 (+1.93%)
5:28:12 PM EDT: $42.03 -0.24 (-0.57%)
Products, Regulatory

EMA PRAC Says Myocarditis, Pericarditis Can Occur After Vaccination With Nuvaxovid

Published: 08/03/2022 13:17 GMT
Novavax, Inc. (NVAX) - Ema - Prac Has Concluded That Myocarditis and Pericarditis Can Occur Following Vaccination With Nuvaxovid.
Ema Says Prac Recommending Listing Myocarditis and Pericarditis As New Side Effects in Product Information for Nuvaxovid.
Ema: Prac Has Also Requested That Marketing Authorisation Holder of Nuvaxovid Provides Additional Data on Risk of Side Effects Occurring.